495 related articles for article (PubMed ID: 22729063)
1. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
Green T; Richardson A; Parry S
N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
[TBL] [Abstract][Full Text] [Related]
2. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
3. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
4. From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?
Shaw C; Cunningham R; Sarfati D
N Z Med J; 2008 Aug; 121(1279):84-95. PubMed ID: 18709051
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
6. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
Nnoaham KE; Lines C
Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
[TBL] [Abstract][Full Text] [Related]
7. Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?
Hazazi R; Rozen P; Leshno M; Levi Z; Samuel Z; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2010 Feb; 31(4):523-33. PubMed ID: 19925498
[TBL] [Abstract][Full Text] [Related]
8. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
9. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
[TBL] [Abstract][Full Text] [Related]
10. Prospects for population colorectal cancer screening in New Zealand.
Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C
N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251
[TBL] [Abstract][Full Text] [Related]
11. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
[TBL] [Abstract][Full Text] [Related]
12. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
13. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
14. French colorectal cancer screening pilot programme: results of the first round.
Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J
J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097
[TBL] [Abstract][Full Text] [Related]
15. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators.
Reeder AI
N Z Med J; 2011 Mar; 124(1331):11-7. PubMed ID: 21725408
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
[TBL] [Abstract][Full Text] [Related]
17. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
19. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
20. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
